Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: A feasibility and efficacy study on a cancer institute based population

Annals of Oncology

Volumn 17, Issue 8, 2006, Pages 1328-1332

  Bleiberg, Harry ^a   Autier, P ^a   Huet, F ^a   Schrauwen, A M ^a   Staquet, E ^a   Delaunoit, T ^a   Hendlisz, A ^a   Wyns, C ^a   Panzer, J M ^a   Caucheteur, B ^a   Eisendrath, P ^a   Grivegnee A ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Colorectal cancer; Screening; Sigmoidoscopy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BELGIUM; CANCER CENTER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PLANNING; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGMOIDOSCOPY;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SIGMOIDOSCOPY;

EID: 33747888014     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl101     Document Type: Article

References (28)

1. Ferlay J, Bray F, Sankila R, Parkin DM (eds). Eucan - Cancer incidence, mortality and prevalence in the European Union. IARC Cancer base no. 4. Lyon: IARC 1999.
2. Winawer SJ, Zauber AG, Diaz B. The National Polyp Study: Temporal sequence of evolving colorectal cancer from the normal colon. Gastrointestinal Endosc 1987; 203-207.
3. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309.
4. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
5. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 329: 672.
6. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 38: 1467-1471.
7. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
8. Ahlquist DA, Wieand HS, Moertel CG et al. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993; 269: 1262-1267.
9. Gotzsche P. Screening for colorectal cancer. Lancet 1997; 349: 356.
10. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343: 162-168.
11. Imperiale TF, Wagner DR, Lin CY et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-174.
12. Lieberman DA, Weiss DG. One-tie screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 2001; 345: 555-560.
13. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: Baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-1300.
14. Coebergh JW, Janssen M, Louwman M, Voogd A. Cancer, incidence, care and survival in the south of the Netherlands, 1995-1999. Eindhoven, The Netherlands: IKZ, Comprehensive Cancer Centre South 2001.
15. RMT. Registre Morphologique de Tumeurs. Nouveaux cas au Grand-Duché de Luxembourg, année 1995, 1996, 1997, Laboratoire National de la Sant. Luxembourg, 1995, 1996, 1997.
16. Schoenfeld P, Shod J, Ornseth E et al. Predictive value of diminutive colonic adenoma trial. The PREDICT trial. Clin Gastroenterol Hepatol 2003; 1: 195-201.
17. Schoen RE, Corle D, Cranston L et al. Is colonoscopy needed for the non-advanced adenoma found on sigmoidoscopy. Gastroenterology 1998; 115: 533-541.
18. Gondal J, Grotmal T, Hostad B et al. Grading of distal colorectal adenomas as predictors for proximal colonic neoplasia and choice of endoscope in population screening: Experience from the Norwegian Colorectal Cancer Prevention Study (NORCCAP) Gut 2003; 52: 398-403.
19. Winawer SJ, Zauber AG, O'Brien MJ et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901-906.
20. Avidan B, Sonnenberg A, Schnell TG et al. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol 2002; 97: 1524-1529.
21. Yood MU, Oliveria S, Boyer JG et al. Colon polyp recurrence in a managed care population. Arch Intern Med 2003; 163: 422-426.
22. Jorgensen OD, Kronborg O, Fenger C. A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma follow-up study. Scand J Gastroenterol 1995; 30: 686-692.
23. Amonkar MM, Hunt TL, Zhou Z, Jin X. Surveillance patterns and polyp recurrence following diagnosis and excision of colorectal polyps in a medicare population. Cancer Epidemiol Biomarkers Prev 2005; 14: 417-421.
24. Mitchell RJ, Campbell H, Farrington SM et al. Prevalence of family history of colorectal cancer in the general population. Br J Surg 2005; 92: 1161-1164.
25. Sandhu MS, Luben R, Khaw KT. Prevalence and family history of colorectal cancer: Implications for screening. J Med Screen 2001; 8: 69-72.
26. Slattery ML, Kinney AY, Levin TR. Factors associated with colorectal cancer screening in a population-based study: The impact of gender, health care source, and time. Prev Med 2004; 38: 276-283.
27. Ramji F, Cotterchio M, Manno M et al. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005; 29: 221-226.
28. Bazzoli F, Fossi S, Sottili S et al. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastronterology 1995; 109: 783-788.